This paper analyses the underlying discourses in Indiaís on-going public policy reforms and debates in the pharmaceutical sector. It identifies the dominant discourse and discusses its impact on consumers in the context of Indiaís contemporary epidemiological and demographic transition, political agenda, economic ambitions, market dynamics and legal framework.